도파민/세로토닌 길항성 비정형 항정신병약물로 치료 중인 정신분열병 환자에서 체중 증가의 관련 요인

키워드

참고문헌 (54)

1. "Weight gain during neuroleptic treatment", 18, pp.171~175 (1981)
2. "Health risks and treatment implications", 76, pp.1407~1412 (1983)
3. "Weight gain associated with antipsychotic drugs", 60, pp.20~24 (1999)
4. "Antipsychotics-induced weight gain:A comprehensiveresearch synthesis", 156, pp.1686~1696 (1999)
5. "Antipsychotic metaboliceffects:weight gain,diabetes mellitus,and lipid abnormalities", 46, pp.273~281 (2001)
6. "Weight gain in adolescents treatedwith risperidone and conventional antipsychotics over six months", 8, pp.151~159 (1988)
7. "Weight gain amongschizophrenic patients treated with clozapine", 149, pp.689~690 (1992)
8. "Treatment of negative and cognitive symptoms", 1, pp.25~30 (1999)
9. "Neuropsychological changein patients with schizophrenia after treatment with quetiapine orhaloperidol", 26, pp.137~149 (2001)
10. "Induction of obesity by psychotropic drug", 499, pp.19~21 (1987)
11. "Determinant of medicationcompliance in schizophrenia:empirical and clinical findings", 23, pp.637~651 (1997)
12. "Medical hazards of obesity", 119, pp.655~660 (1993)
13. "Diabetes mellitusin schizophrenia patients", 37, pp.68~73 (1996)
14. "A review of the effect of atypical antipsychotics onweight", 28, pp.83~96 (2003)
15. "Beitrage zum verlauf des korpergewichtes bei psychosen", 59, pp.531~534 (1947)
16. "Clinical biochemical and physiologicalstudies in cases of recurrent schizophrenia", 98, pp.100~ (1952)
17. "Change in weight in patients receiving a", pp.289~303
18. "Kaplan & Sadock’s Synopsis of Psychiatry", pp.982~ (2003)
19. "Effect of cyproheptadineon the feeding and satiety center in the rat", 1, pp.449~459 (1973)
20. "Novel antipsychotics:Comparison of weight gainliabilities", 60, pp.358~363 (1999)
21. "Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanismof action", 24, pp.341~353 (2000)
22. "Hypothalamic dopamine andserotonin in the regulation of food intake", 16, pp.843~857 (2000)
23. "A clinical trial of the efficacy andacceptability of D-fenfluramine in the treatment of neuroleptic-inducedobesity", 153, pp.208~213 (1988)
24. "Factors influencing acute weight change in patients with schizophreniatreated with olanzapine,haloperidol,or risperidone", 62, pp.231~238 (2001)
25. "Antipsychotic-induced weight gain and therapeuticresponse:A differential association", 22, pp.244~251 (2002)
26. "Clozapine andbody mass change", 43, pp.520~524 (1998)
27. "Weight gain induced by clozapine", 5, pp.437~440 (1995)
28. "Olanzapine:Weight gain and therapeutic efficacy(letter)", 19, pp.273~275 (1999)
29. "Clozapine-induced weight gain:prevalence and clinical relevance", 149, pp.68~72 (1992)
30. "Differential effect ofclozapine on weight:A controlled study", 153, pp.817~819 (1996)
31. "Elevated levels of insulin,leptin,and blood lipid in olanzapine-treated patients with schizophreniaor related psychoses", 61, pp.742~749 (2000)
32. "Food intake and energy balance inDiabetes Mellitus", pp.175~192 (1997)
33. "Change in glucose & cholesterol levels in patientswith schizophrenia treated with typical or atypical antipsychotics", 160, pp.290~296 (2003)
34. "Long-term olanzapinetreatment: weight change and weight-related health factors inschizophrenia", 62, pp.92~100 (2001)
35. "Effect of chlorpromazine on bloodglucose and plasma insulin in man", 11, pp.15~18 (1977)
36. "A kinetic study of chlorpromazineon the hyperglycemic response in rat:effect of chlorpromazine onplasma glucose", 11, pp.492~503 (1988)
37. "Atypical antipsychotics-induceddifferences in glucose regulation in schizophrenia independent ofdifferences in adiposity", 26, pp.275~ (2000)
38. "The relationship betweenprolactin levels and risk of breast cancer in premenopausal women", 23, pp.1541~1548 (1987)
39. "Endocrine and psychological evaluation of women with recentweight gain", 20, pp.53~63 (1995)
40. "Prevalence of obesity in outpatientsreceiving antipsychotic drug correlation with serum prolactin levels" (1988), Venezuelan Psychiatric Association Press
41. "Body weight gain induced by antipsychotic drug:mechanismand management", 100, pp.81~88 (1999)
42. "Prolactin directlyinhibits basal as well as gonadotropin-stimulated secretion ofprogesterone and 17(beta)-estradiol in the human ovary", 99, pp.1246~1250 (1982)
43. "Gonadal effect on food intake and adiposity:ametabolic hypothesis", 22, pp.583~594 (1979)
44. "Metabolic fuel and reproduction in femalemammals", 16, pp.235~272 (1992)
45. "Body weight gain after administrationof antipsychotic drugs:correlation with leptin,insulin,andreproductive hormones", 33, pp.81~88 (2000)
46. "Weightgain associated with increased food intake and low habitual activitylevel in male adolescent schizophrenic inpatients treated with olanzapine", 6, pp.2002~
47. "Olanzapine을투여 받은 정신분열병 환자의 체중. 체질량지수, 렙틴, 인슐린,공복시 혈당의 변화.", 40, pp.1240~1246 (2001)
48. "항정신병약물을 투여받은 정신분열병환자의 체중,BMI,및 혈장 leptin 종도의 변화", 6, pp.111~118 (2000)
49. "Diagnostic and StatisticalManual of Mental Disorder" (1994)
50. "A standardised psychiatricassessment for rating chronic psychotic patients", 55, pp.299~308 (1977)
51. "The positive and negative syndromescale for schizophrenia", 13, pp.261~276 (1987)
52. "Glucoseintolerance with atypical antipsychotics", 25, pp.1107~1116 (2002)
53. "Clozapine, diabetes mellitus, weight gain, andlipid abnormalities: a five-year naturalistic study", 157, pp.975~981 (2000)
54. "Prolactinoma and body weight:a retrospective study", 125, pp.293~396

관련 논문AI추천